MyAverix Finance
AU · Healthcare
Tetratherix Ltd (TTX)
Biotechnology
Tetratherix Ltd (TTX) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TTX
Tetratherix Ltd (TTX) — FAQ
What is TTX's P/E ratio?
The price-to-earnings (P/E) ratio for Tetratherix Ltd (TTX) is 25.00 (data as of 2026-05-23).
Does Tetratherix Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Tetratherix Ltd (TTX). Check the MyAverix Finance app for the latest dividend data.
What sector is Tetratherix Ltd in?
Tetratherix Ltd (TTX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TTX listed on?
TTX is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.